by | Nov 21, 2024 | Lupus Foundation of America, News & Events
Adicet Bio announced the first person with lupus nephritis (LN) has been dosed with ADI-001, an investigational allogeneic gamma delta CAR T cell therapy that targets B cells. The phase 1 study of ADI-001 in autoimmune diseases is currently underway with preliminary...
by | Nov 19, 2024 | Lupus Foundation of America
The American College of Rheumatology (ACR) 2024 Convergence has just concluded, showcasing significant advancements and groundbreaking discoveries in lupus research. The annual meeting, held from November 14-19 in Washington D.C., featured thousands of new studies...
by | Nov 18, 2024 | Lupus Foundation of America, News & Events
Today at the American College of Rheumatology (ACR) Annual Meeting, Convergence 2024, the ACR released a summary of a new guideline for the screening, treatment and management of lupus nephritis (lupus-related kidney disease).The guideline offers evidence-based,...
by | Nov 14, 2024 | Lupus Foundation of America
How do I explain to a 9 year old that I cannot do all the things we used to do before or spend as much time with them?Kaz Brown, a professional volleyball player whose mother has lived with lupus for the past 20 years, recommended two books, Mommy, What is Lupus? by...
by | Nov 14, 2024 | Lupus Foundation of America, News & Events
The Lupus Foundation of America (LFA), along with numerous researchers funded by the Foundation, will present novel lupus discoveries as part of the American College of Rheumatology Convergence 2024 meeting in Washington D.C. from November 14-19, 2024. “The pathway...
by | Nov 12, 2024 | Lupus Foundation of America, News & Events
Seattle Children’s announced they are now enrolling participants in the first CAR T cell clinical trial for children with systemic lupus erythematosus (SLE). This is the first clinical trial in the U.S. examining CAR T cell therapy in a pediatric population. The phase...
